BioStem Technologies (BSEM) Stock Chart & Stock Price History $13.74 +0.63 (+4.80%) As of 06/20/2025 03:56 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock BioStem Technologies Stock Price Performance The BioStem Technologies (BSEM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 64.15%, with a year-to-date return of -0.73%. In the past month, the stock has increased 16.93%, reflecting recent market activity. As of the latest close, BioStem Technologies traded at $13.74 with a market cap of $229.44 million and volume of 28,268 shares. Receive BSEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioStem Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.65%1 Month Performance+16.93%3 Month Performance+26.98%Year-To-Date Performance-0.73%1 Year Performance+64.15% BSEM Stock Chart for Saturday, June, 21, 2025 BSEM Chart by TradingView BioStem Technologies Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/20/2025$13.11$13.74+4.80%$13.80$13.1728,268 shs$229.44 million06/19/2025$13.11$13.11$14.10$13.1125,536 shs$218.94 million06/18/2025$14.15$13.11-7.35%$14.10$13.1125,536 shs$218.94 million06/17/2025$13.65$14.15+3.66%$14.15$13.4024,681 shs$236.36 million06/16/2025$13.75$13.65-0.73%$14.00$13.6015,693 shs$228.01 million06/13/2025$13.90$13.75-1.08%$13.77$13.5514,849 shs$229.68 million06/12/2025$13.97$13.90-0.50%$14.06$13.6621,943 shs$232.19 million06/11/2025$14.02$13.97-0.35%$14.20$13.7527,649 shs$233.36 million06/10/2025$14.30$14.02-1.99%$14.37$13.7044,253 shs$234.18 million06/09/2025$14.17$14.30+0.98%$14.52$14.1555,928 shs$238.93 million Get the Latest News and Ratings for BSEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioStem Technologies and its competitors with MarketBeat's FREE daily newsletter. 06/06/2025$13.65$14.17+3.77%$14.35$13.7172,794 shs$236.61 million06/05/2025$13.10$13.65+4.20%$14.34$12.70152,940 shs$228.01 million06/04/2025$12.45$13.10+5.22%$13.85$12.45120,226 shs$218.82 million06/03/2025$10.70$12.45+16.36%$12.47$10.90142,602 shs$207.97 million06/02/2025$11.07$10.70-3.31%$11.15$10.0073,174 shs$178.73 million05/30/2025$11.22$11.07-1.37%$11.70$11.0726,423 shs$184.85 million05/29/2025$11.65$11.22-3.65%$11.65$11.1017,770 shs$187.42 million05/28/2025$11.46$11.65+1.63%$11.80$11.4632,627 shs$194.52 million05/27/2025$11.98$11.46-4.32%$11.98$11.0062,967 shs$191.39 million05/26/2025$11.98$11.98$12.00$10.9141,955 shs$200.03 million05/23/2025$12.00$11.98-0.19%$12.00$10.9141,955 shs$200.03 million05/22/2025$11.75$12.00+2.11%$12.00$11.7515,173 shs$200.41 million05/21/2025$12.02$11.75-2.25%$12.28$11.6153,133 shs$196.27 million05/20/2025$11.97$12.02+0.43%$12.25$11.7553,307 shs$200.80 million Related Companies Collegium Pharmaceutical Stock Chart The Pennant Group Stock Chart MiMedx Group Stock Chart agilon health Stock Chart Syndax Pharmaceuticals Stock Chart Akebia Therapeutics Stock Chart CureVac Stock Chart Praxis Precision Medicines Stock Chart InMode Stock Chart Zymeworks Stock Chart Receive BSEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioStem Technologies and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:BSEM) was last updated on 6/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioStem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioStem Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
